FDA reviewers' requests for more premarket data must be clearly explained, Burlington says.
This article was originally published in The Gray Sheet
Executive Summary
FDA DEVICE REVIEWERS' REASONS FOR ADDITIONAL PREMARKET DATA REQUESTS should be clearly explained to sponsors of premarket submissions, Bruce Burlington, director of FDA's Center for Devices and Radiological Health, says in a recent memo to premarket review staff. The device center must not only "clearly understand why we want more data and what it is we want," Burlington says, but must also "clearly and explicitly convey" to the sponsor "what we are looking for and why we want it."
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.